BCAX
Bicara Therapeutics Inc.
22.00$
-2.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 74.4% | 98.8% | 88.3% | 97.9% | |
| 62.0% | 98.5% | 86.0% | 22.4% | |
| 62.0% | 98.5% | 86.0% | 96.2% | |
| 357.8% | 6.6% | 13.6% | 6.9% | |
| 356.5% | 6.4% | 3.2% | 6.7% | |
| – | 0.1% | 0.1% | 0.3% | |
| 76.6% | 1.4% | 0.8% | 1.8% | |
| -257.8% | 93.4% | 86.4% | 93.1% | |
| -1,507.3% | -65.4% | -38.8% | -83.3% | |
| 772.2% | 22.1% | 9.6% | 12.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.